To determine the effect of CX3CR1 deficiency on AD-like pathology in PS1-APP mice, we assessed Aβ load and levels in brains of PS1-APP transgenic mice and PS1-APP-CX3CR1 deficient mice at 10 months of age. This evidence concerns the gene PSEN1 and Alzheimer disease.